People with multiple sclerosis may have a greater overall risk of developing cancer than those without the autoimmune disease. The highest risks are associated with respiratory, urinary and central nervous system cancers.
Scientists have long believed that glioblastoma multiforme, the most aggressive type of primary brain tumor, begins in glial cells that make up supportive tissue in the brain or in neural stem cells. Researchers found that the tumors can originate from other types of differentiated cells in the nervous system, including cortical neurons.
A new study raises questions about the link between cell phone use and an increased risk of developing brain cancer. Researchers found little evidence to suggest the rate of brain cancer incidents has risen in any age group as a result of cell phone usage.
Researchers have successfully bypassed the blood-brain barrier using a laser probe to help deliver chemotherapy drugs to glioblastoma patients.
A new study study of the genetic factors underlying glioma formation in dogs reveals three genes associated with the cancer. The findings may prove helpful in diagnosis and developing new treatments for humans.
Recurrent gliomas could have genetic profiles which are different from those of the initial tumors that spawned them, a new study reports.
Researchers report muscle stem cells may give rise to rhabdomyosarcoma, a rare cancer that affects the muscles in Duchenne muscular dystrophy. The study also identifies two genes linked to the tumor's growth.
Researchers reveal the important role of microRNAs in regulating neuroblastoma brain cancer development.
Researchers report the addition of an FDA approved chemotherapy drug called hydroxyyurea to temozolomide helps to increase survival rates in animal models of glioblastoma.